Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis | Zendy

Valérie Leclair | Zendy; Océane LandonCardinal | Zendy; Rohit Aggarwal | Zendy; Nick Bansback | Zendy; Craig Campbell | Zendy; Brian M. Feldman | Zendy; Martin Jarry | Zendy; Suzan McNamara | Zendy; Barbara White | Zendy; Marie Hudson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis

Author(s) -

Valérie Leclair,

Océane LandonCardinal,

Rohit Aggarwal,

Nick Bansback,

Craig Campbell,

Brian M. Feldman,

Martin Jarry,

Suzan McNamara,

Barbara White,

Marie Hudson

Publication year - 2020

Publication title -

the journal of rheumatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.577

H-Index - 178

eISSN - 1499-2752

pISSN - 0315-162X

DOI - 10.3899/jrheum.200480

Subject(s) - clinical trial , medicine , myositis , myopathy , inflammatory myopathy , physical therapy , pathology

The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research